Sarepta Therapeutics, Inc.

of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan

. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated February 25, 2026 104 The cover page from this Current Rep